The systemic immune‐inflammation index is associated with an increased risk of incident cancer—A population‐based cohort study

Several studies found that the systemic immune‐inflammation index (SII) is a prognostic factor for mortality in patients with solid tumors. It is unknown whether an increased SII in generally healthy individuals reflects a risk for developing cancer. Our objective was to investigate the association...

Ausführliche Beschreibung